systematic review

Meta-Analysis Validates TissueCypher for Esophageal Cancer Risk

FRIENDSWOOD, Texas — December 12, 2025 — Castle Biosciences, Inc., a diagnostics company advancing precision medicine in gastroenterology, announced...

By cGxPwire Editor
December 15, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

systematic review

Meta-Analysis Validates TissueCypher for Esophageal Cancer Risk